On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
1d
Hosted on MSNInsmed's NDA for Lung Disease Drug Gets FDA's Priority ReviewInsmed Incorporated INSM announced that the FDA has accepted its new drug application (“NDA”) seeking approval of its ...
BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM), a biopharmaceutical company with a market capitalization of $14.57 ...
A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...
Developers "need some time to digest all of your feedback," but say they're "committed to getting this right." ...
Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to ...
President Trump is allegedly displeased with his immigration officials despite them having reportedly already arrested 11,000 illegal aliens.
The dismantling of the U.S. Agency for International Development will deliver a major blow to efforts including humanitarian ...
Going out to eat? See which Okaloosa County restaurants were rated best by inspectors, and which failed the test.
Master sprint planning meetings with our complete guide. Learn how to set a sprint goal and break down tasks to boost ...
HB 1006 would create a prosecutor review board who would determine if a prosecutor is noncompliant with state laws and if they get state funds.
REC Silicon ASA ( OTCPK:RNWEF) Q4 2024 Earnings Conference Call February 6, 2025 2:00 AM ET Welcome to REC Silicon's Fourth Quarter 2024 Earnings Call. My name is Kurt Levens, and I am REC Silicon's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results